ReGen III Announces Patent Update and Extension of Financing

Following the issuance of this patent, ReGen III has nineteen (19) patents issued, allowed, or accepted for the Company's ReGen™ process, in addition to thirteen (13) patents pending globally. The Company also announces that, further to its non-brokered private placement (the "Placement") of up to 2,000 Convertible Debenture Units (the "Units") announced on April 30, 2024 (see that news release for details), and the first tranche closing on May 31, 2024, the Company has received TSX Venture Exchange approva ...